AU Patent

AU2004283059B2 — Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Assigned to Allergan Finance LLC · Expires 2011-02-10 · 15y expired

What this patent protects

Patent listed against metformin-hydrochloride.

Drugs covered by this patent

metformin-hydrochloride (METFORMIN HYDROCHLORIDE)

Patent Metadata

Patent number: AU2004283059B2
Jurisdiction: AU
Classification: —
Expires: 2011-02-10
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Finance LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.